Prognostic factors for multiple myeloma in the era of novel therapies-Reference-Cited by-同舟云学术

Prognostic factors for multiple myeloma in the era of novel therapies

Published:2018-10-26 Issue:11 Volume:11 Page:863-879
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Ziogas Dimitrios C.¹,Dimopoulos Meletios A.¹,Kastritis Efstathios¹

Affiliation:

1. Department of Clinical Therapeutics, School of Medicine, “Alexandra” General Hospital, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2018.1537776

Reference173 articles.

1. Multiple myeloma

2. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

3. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

4. Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

5. Improved survival in multiple myeloma and the impact of novel therapies

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma;European Journal of Radiology Open;2024-12

2. Prevalence, Outcomes and Impact of Disease-Related Complications in the Survival of Multiple Myeloma Patients;Hematology Reports;2024-02-21

3. IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma;2023-10-24

4. 18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma;BMC Medical Imaging;2023-06-27

5. Spinal lesions in multiple myeloma: Primary bone tumors with distinct prognostic factors;Surgical Oncology;2023-06